Our Recommendations
- Mejores prácticas para la atención de pacientes con tuberculosis (2017)
- WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update (2016)
- IMAI district clinician manual: hospital care for adolescents and adults: guidelines for the management of illnesses with limited-resources. Vol. 2 (2011)
- Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice (2019)
- Field Guide for the Management of Drug-Resistant Tuberculosis (2018)
New Publications
- Framework for an Integrated Multisectoral Response to TB, HIV, STIS and Hepatitis in the WHO African Region 2021–2030 (2024)
- The use of next-generation sequencing for the surveillance of drug-resistant tuberculosis: an implementation manual (2023)
- TB Toolbox (2022)
- Manual operativo de la OMS sobre la tuberculosis. Módulo 1: Prevención. Tratamiento preventivo de la tuberculosis (2020)
- Lignes directrices unifiées de l’OMS sur la tuberculose : module 2 : dépistage: dépistage systématique de la tuberculose (2022)
Filter
111
Featured
Recommendations
21
New Publications
29
Language
Document type
No document type
63
Guidelines
24
Manuals
9
Training Material
6
Studies & Reports
3
Fact sheets
3
Situation Updates
1
Resource Platforms
1
Videos
1
Countries / Regions
Russia
4
Ukraine
2
Global
2
India
2
Nepal
1
Colombia
1
Kenya
1
Chile
1
Afghanistan
1
Asia
1
South–East Asia Region
1
Bangladesh
1
South Africa
1
Eastern Europe
1
Brazil
1
Sri Lanka
1
Bhutan
1
Ecuador
1
Pakistan
1
Authors & Publishers
Publication Years
Toolboxes
TB
81
Caregiver
6
HIV
5
Refugee
4
Ebola & Marburg
3
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Guía para países de bajos ingresos. 2 edición
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries
recommended
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
La guía se basa en las buenas prácticas existentes y se ha elaborado con la colaboración de enfermeras que trabajan en una amplia variedad de ámbitos, pero se enfoca principalmente en las áreas con recursos limitados. Representa el punto de vista del personal técnico ...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ...
This guidance provides an overview of interventions to improve early diagnosis of TB and treatment completion in these populations, as well as factors to consider when developing programmes for health communication, awareness and education, and programme monitoring and evaluation
Evidence to decision framework
